PHASE IV CLINICAL TRIAL IS HARD NUT TO CRACK FOR INDUSTRY
New Delhi: In the month of July, Joint DCGI has issued letter to most of the FDC applicant (FDC already approved by state licensing authority) to submit protocol for Phase…
Paradigm Shift in Indian nutraceuticals market by 2020: Study
NEW DELHI: Indian nutraceuticals market is set to grow over two-fold to $6.1 billion by 2020 as consumers become more conscious towards health and fitness, according to a study. The…
Generic vs Branded
New Delhi, The ‘branded’ argument easily scores a very strong point of quality in ‘generics versus branded medicine’ debate, ever after mass women death at a sterilization camp in Chhattisgarh…

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India
Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act
COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients
Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested
FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development
IPC releases draft NFI-2026 to promote rational use of medicines
Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery
US market to dent India pharma earnings even as domestic growth remains firm
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Healthcare, pharma sector to create 2-2.5 million new jobs by 2030